Ashland Inc (ASH) Stock Price, Quote & News

Company Profile

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricu...

Industry: Specialty Chemicals

Sector: Basic Materials

Phone: 302 995 3000

Website: www.ashland.com

Address:

8145 Blazer Drive, Wilmington, United States

BillionerOfKing May. 11 at 10:59 PM

$ASH Current Stock Price: $54.06 Contracts to trade: $55.0 ASH May 15 2026 Call Entry: $0.70 Exit: $1.14 ROI: 62% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

BillionerOfKing May. 7 at 3:19 PM

$ASH Current Stock Price: $54.50 Contracts to trade: $55.0 ASH May 15 2026 Call Entry: $0.95 Exit: $1.44 ROI: 51% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

SuperGreenToday May. 2 at 2:26 AM

$ASH Share Price: $51.80 Contract Selected: Oct 16, 2026 $55 Calls Buy Zone: $2.72 – $3.36 Target Zone: $5.13 – $6.28 Potential Upside: 78% ROI Time to Expiration: 167 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

PenkeInvesting May. 1 at 4:26 AM

Fundamental analysis of $ASH (ASHLAND INC.) based on financial data and reported results. #ASH #ASHLAND

0 · Reply

Estimize Apr. 29 at 8:01 PM

Wall St is expecting 1.19 EPS for $ASH Q3 [Reporting 07/28 AMC] http://www.estimize.com/intro/ash?chart=historical&metric_name=eps&utm_cont

0 · Reply

OfficialStocktwitsUser Apr. 29 at 7:09 PM

$ASH RSI: 28.42, MACD: 0.0101 Vol: 1.94, MA20: 56.07, MA50: 56.02 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

StocktwitsEarnings Apr. 28 at 9:20 PM

$ASH Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.34 down -46.03% YoY • Reported revenue of $964M up 101.25% YoY • Ashland is updating its full-year fiscal 2026 sales guidance to $1,835-$1,870 million and Adjusted EBITDA guidance to $385-$400 million, reflecting slower productivity ramp at Hopewell.

0 · Reply

SuperGreenToday Apr. 15 at 11:01 AM

$ASH Share Price: $55.35 Contract Selected: Oct 16, 2026 $55 Calls Buy Zone: $3.44 – $4.25 Target Zone: $5.54 – $6.77 Potential Upside: 52% ROI Time to Expiration: 183 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Estimize Mar. 4 at 2:03 PM

Wall St is expecting 0.97 EPS for $ASH Q2 [Reporting 05/05 AMC] http://www.estimize.com/intro/ash?chart=historical&metric_name=eps&utm_cont

0 · Reply

SuperGreenToday Feb. 18 at 2:53 PM

$ASH Share Price: $60.99 Contract Selected: Jul 17, 2026 $60 Calls Buy Zone: $5.65 – $6.97 Target Zone: $9.22 – $11.27 Potential Upside: 54% ROI Time to Expiration: 148 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Ashland upgraded to Buy from Neutral at Seaport Research

May 5, 2026, 5:01 PM EDT - 7 days ago

Ashland board authorizes quarterly dividend

2026-05-04T12:22:23.000Z - 8 days ago

Ashland price target lowered to $58 from $63 at Morgan Stanley

2026-05-01T11:59:14.000Z - 11 days ago

Ashland price target lowered to $60 from $70 at Deutsche Bank

2026-04-30T15:33:09.000Z - 12 days ago

Ashland price target lowered to $65 from $70 at JPMorgan

Apr 29, 2026, 9:00 AM EDT - 13 days ago

Ashland Earnings Call Transcript: Q2 2026

2026-04-28T21:58:55.000Z - 14 days ago

Ashland reports Q2 adjusted EPS 91c, consensus 94c

2026-04-28T21:57:00.000Z - 14 days ago

Ashland lowers FY26 revenue view to $1.84B-$1.87B from $1.84B-$1.91B

Apr 28, 2026, 5:01 PM EDT - 14 days ago

Ashland reports second quarter fiscal 2026 results and updates full-year outlook

Apr 15, 2026, 5:01 PM EDT - 27 days ago

Ashland sets date for second-quarter fiscal 2026 earnings release and conference call webcast

2026-04-06T13:38:04.000Z - 5 weeks ago

Ashland price target lowered to $65 from $70 at Mizuho

2026-03-23T13:21:45.000Z - 7 weeks ago

Ashland price target lowered to $56 from $70 at Argus

2026-03-23T11:01:17.000Z - 7 weeks ago

Ashland to implement pricing actions across product portfolio

2026-03-23T11:00:52.000Z - 7 weeks ago

Ashland implementing pricing actions across product portfolio

Mar 23, 2026, 6:55 AM EDT - 7 weeks ago

Ashland implements pricing actions across product portfolio in response to market volatility

Mar 17, 2026, 5:01 PM EDT - 2 months ago

Ashland CFO to discuss current market environment at the Gabelli Funds' 17th Annual Specialty Chemicals Symposium

2026-02-18T13:16:08.000Z - 2 months ago

Ashland price target raised to $62 from $53 at Evercore ISI

2026-02-09T12:11:22.000Z - 3 months ago

Ashland says EPA approves petition for agrimer eco-coat polymer seed coating

Feb 9, 2026, 7:00 AM EST - 3 months ago

Ashland agrimer™ eco-coat polymer seed coating from the Transformed Vegetable Oils (TVO) platform receives approval for all food and non-food uses in pesticide formulations including for sale in the U.S.

2026-02-09T11:46:41.000Z - 3 months ago

Ashland price target raised to $63 from $60 at Morgan Stanley

2026-02-04T14:20:12.000Z - 3 months ago

Ashland price target raised to $73 from $70 at UBS

2026-02-04T12:21:41.000Z - 3 months ago

Ashland price target lowered to $70 from $77 at JPMorgan

2026-02-04T12:10:59.000Z - 3 months ago

Ashland price target raised to $70 from $58 at Deutsche Bank

Feb 3, 2026, 9:00 AM EST - 3 months ago

Ashland Earnings Call Transcript: Q1 2026

2026-02-02T22:10:10.000Z - 3 months ago

Ashland affirms FY6 revenue view of $1.835B-$1.905B

2026-02-02T22:05:16.000Z - 3 months ago

Ashland reports Q1 EPS 26c, consensus 25c

Feb 2, 2026, 5:01 PM EST - 3 months ago

Ashland reports first quarter fiscal 2026 results and narrows full-year outlook

2026-01-27T12:11:55.000Z - 3 months ago

Ashland, Univar Solutions announce exclusive distribution partnership

Jan 27, 2026, 7:02 AM EST - 3 months ago

Univar Solutions and Ashland Forge Exclusive Partnership for Cellulose Ethers in Food and Beverage Sector Throughout EMEA

Jan 20, 2026, 5:01 PM EST - 4 months ago

Ashland sets date for first-quarter fiscal 2026 earnings release and conference call webcast

Jan 20, 2026, 10:30 AM EST - 4 months ago

Ashland Transcript: AGM 2026

2026-01-12T14:13:25.000Z - 4 months ago

Ashland price target raised to $70 from $64 at UBS

Nov 5, 2025, 10:00 AM EST - 6 months ago

Ashland Earnings Call Transcript: Q4 2025

Nov 4, 2025, 5:01 PM EST - 6 months ago

Ashland reports fourth quarter fiscal 2025 results and issues outlook for full-year 2026

Oct 30, 2025, 5:01 PM EDT - 6 months ago

Ashland changes start time for fourth-quarter fiscal 2025 earnings conference call webcast

Oct 23, 2025, 7:00 AM EDT - 7 months ago

Ashland sets date for fourth-quarter fiscal 2025 earnings release and conference call webcast

Oct 14, 2025, 5:01 PM EDT - 7 months ago

Ashland announces Sandy Klugman, director, investor relations

Sep 30, 2025, 5:01 PM EDT - 8 months ago

Ashland production unit at Calvert City is offline, equipment requires replacement with no impact expected to customer orders

Jul 30, 2025, 10:00 AM EDT - 10 months ago

Ashland Earnings Call Transcript: Q3 2025

Jul 29, 2025, 5:01 PM EDT - 10 months ago

Ashland reports third quarter fiscal 2025 results and narrows full-year outlook range

Jul 21, 2025, 5:00 PM EDT - 10 months ago

Whitaker named senior vice president and chief financial officer, Ashland

Jul 16, 2025, 5:00 PM EDT - 10 months ago

Ashland sets date for third-quarter fiscal 2025 earnings release and conference call webcast

Jul 14, 2025, 5:00 PM EDT - 10 months ago

Operations leadership changes announced at Ashland

Jul 8, 2025, 5:00 PM EDT - 11 months ago

Ashland advances strategic $60MM network optimization

May 29, 2025, 9:00 AM EDT - 1 year ago

Ashland Transcript: Innovation Day 2025

May 28, 2025, 5:00 PM EDT - 1 year ago

Ashland hosts Innovation Day for analysts and investors

May 8, 2025, 6:45 AM EDT - 1 year ago

Valvoline Inc. Announces Kevin Willis as Chief Financial Officer

VVV

May 5, 2025, 5:00 PM EDT - 1 year ago

Ashland announces executive leadership changes

May 1, 2025, 10:00 AM EDT - 1 year ago

Ashland Earnings Call Transcript: Q2 2025

Apr 30, 2025, 5:01 PM EDT - 1 year ago

Ashland reports second quarter fiscal 2025 results and revises full-year outlook

Apr 29, 2025, 9:00 AM EDT - 1 year ago

Ashland Place Completes Two New Financing Facilities for Sirius Aviation Capital

Apr 17, 2025, 6:30 AM EDT - 1 year ago

Ashland sets date for second-quarter fiscal 2025 earnings release and conference call webcast

Apr 1, 2025, 6:59 AM EDT - 1 year ago

Ashland expands pharmaceutical plant for Aquarius™ tablet coatings and commissions new microbial protection capability in Brazil, demonstrating strategy to globalize, innovate, and invest

Mar 28, 2025, 6:59 AM EDT - 1 year ago

Ashland to host 2025 Innovation Day for analysts and investors

Mar 17, 2025, 7:00 AM EDT - 1 year ago

Ashland completes sale of Avoca business to Mane

Feb 10, 2025, 12:53 PM EST - 1 year ago

The Best Materials Stocks to Buy

AVY BALL DD FMC GPK PKG RPM

Jan 29, 2025, 9:00 AM EST - 1 year ago

Ashland Earnings Call Transcript: Q1 2025

Jan 28, 2025, 5:01 PM EST - 1 year ago

Ashland reports financial results for first quarter fiscal 20251, reiterates outlook for full-year fiscal 2025

Jan 14, 2025, 7:00 AM EST - 1 year ago

Ashland sets date for first-quarter fiscal 2025 earnings release and conference call webcast

Dec 23, 2024, 5:01 PM EST - 1 year ago

Ashland signs definitive agreement to sell Avoca business to Mane

Dec 10, 2024, 9:00 AM EST - 1 year ago

Ashland Transcript: Status Update

Dec 9, 2024, 5:01 PM EST - 1 year ago

Ashland rings opening bell at NYSE recognizes 100-year anniversary

Dec 9, 2024, 6:30 AM EST - 1 year ago

Ashland celebrates solvers, recognizes 100 years of innovation by planting trees to restore local ecosystems and support sustainable sourcing

Nov 8, 2024, 7:00 AM EST - 1 year ago

Ashland to host live 2024 strategy update event for analysts and investors

Nov 7, 2024, 9:00 AM EST - 1 year ago

Ashland Earnings Call Transcript: Q4 2024

Oct 28, 2024, 5:00 PM EDT - 1 year ago

Ashland sets date for fourth-quarter fiscal 2024 earnings release and conference call webcast

Sep 19, 2024, 10:06 AM EDT - 1 year ago

D.A. Davidson Acts as Exclusive Financial Advisor to Turnspire Capital Partners for Debt Financing in Support of Turnspire's Acquisition of Pharmachem

Sep 3, 2024, 7:00 AM EDT - 1 year ago

Ashland completes sale of nutraceuticals business

Sep 3, 2024, 7:00 AM EDT - 1 year ago

Pharmachem Innovations Launches as a Leading Independent Provider of Nutraceuticals Products and Solutions

Sep 3, 2024, 7:00 AM EDT - 1 year ago

Turnspire Capital Partners Completes Acquisition of Pharmachem from Ashland

Aug 7, 2024, 10:00 AM EDT - 1 year ago

Ashland Earnings Call Transcript: Q3 2024

Aug 6, 2024, 5:01 PM EDT - 1 year ago

Ashland reports financial results1 for third quarter fiscal 2024, issues outlook for fourth quarter and full-year fiscal 2024

Jul 17, 2024, 7:00 AM EDT - 1 year ago

Ashland sets date for fiscal 2024 third-quarter earnings release and conference call webcast

Jun 18, 2024, 7:00 AM EDT - 2 years ago

Ashland achieves certification by Fair Wage Network

May 8, 2024, 5:01 PM EDT - 2 years ago

Ashland Board appoints Ashish K. Kulkarni as new director

May 7, 2024, 7:00 AM EDT - 2 years ago

Turnspire Capital Partners to Acquire Ashland Nutraceuticals Business

May 7, 2024, 6:59 AM EDT - 2 years ago

Ashland signs definitive agreement to sell nutraceuticals business to Turnspire Capital Partners

May 1, 2024, 9:00 AM EDT - 2 years ago

Ashland Earnings Call Transcript: Q2 2024

Apr 30, 2024, 5:01 PM EDT - 2 years ago

Ashland reports financial results1 for second quarter fiscal 2024; issues outlook for third quarter and full-year fiscal 2024

Apr 18, 2024, 6:59 AM EDT - 2 years ago

Ashland sets date for fiscal 2024 second-quarter earnings release and conference call webcast

Apr 15, 2024, 6:59 AM EDT - 2 years ago

Ashland Board appoints Scott A. Tozier as new director

BillionerOfKing May. 11 at 10:59 PM

0 · Reply

BillionerOfKing May. 7 at 3:19 PM

0 · Reply

SuperGreenToday May. 2 at 2:26 AM

0 · Reply

PenkeInvesting May. 1 at 4:26 AM

Fundamental analysis of $ASH (ASHLAND INC.) based on financial data and reported results. #ASH #ASHLAND

0 · Reply

Estimize Apr. 29 at 8:01 PM

Wall St is expecting 1.19 EPS for $ASH Q3 [Reporting 07/28 AMC] http://www.estimize.com/intro/ash?chart=historical&metric_name=eps&utm_cont

0 · Reply

OfficialStocktwitsUser Apr. 29 at 7:09 PM

0 · Reply

StocktwitsEarnings Apr. 28 at 9:20 PM

0 · Reply

SuperGreenToday Apr. 15 at 11:01 AM

0 · Reply

Estimize Mar. 4 at 2:03 PM

Wall St is expecting 0.97 EPS for $ASH Q2 [Reporting 05/05 AMC] http://www.estimize.com/intro/ash?chart=historical&metric_name=eps&utm_cont

0 · Reply

SuperGreenToday Feb. 18 at 2:53 PM

0 · Reply

Broview Feb. 14 at 8:20 AM

$ASH cautiously adding?

0 · Reply

ZacksResearch Feb. 10 at 5:24 PM

$ASH just cleared a major regulatory hurdle — and the market may be underpricing it 👀 Ashland’s agrimer eco-coat polymer seed coating just won U.S. EPA approval, expanding market access and enabling use across both food and non-food pesticide formulations — a meaningful unlock for adoption. What this approval could mean for Ashland’s growth story 👉 https://www.zacks.com/stock/news/2847694/ashs-agrimer-eco-coat-gets-epa-approval-for-pesticide-use-in-the-us?cid=sm-stocktwits-2-2847694-teaser-32858&ADID=SYND_STOCKTWITS_TWEET_2_2847694_TEASER_32858

0 · Reply

ZacksResearch Feb. 10 at 4:24 PM

$ASH gets EPA approval for new seed coating — time to watch this space! 🌱 Their agrimer eco-coat polymer, built on patented TVO technology, is now cleared for use in food and non-food pesticide formulations, boosting its market reach and sustainability impact. See why this innovation could drive growth for Ashland 👉 https://www.zacks.com/stock/news/2847694/ashs-agrimer-eco-coat-gets-epa-approval-for-pesticide-use-in-the-us?cid=sm-stocktwits-2-2847694-body-32856&ADID=SYND_STOCKTWITS_TWEET_2_2847694_BODY_32856

0 · Reply

twib Feb. 9 at 10:32 AM

$ASH

0 · Reply

Estimize Feb. 3 at 1:42 PM

$ASH reported 0.26 EPS and 386.00 revenue for Q1. http://www.estimize.com/intro/ash?chart=historical&metric_name=eps&utm_content=ASH&utm_me

0 · Reply

ZacksResearch Feb. 3 at 12:06 PM

$ASH just beat earnings — but the top line tells a different story. ⚠️ Ashland’s Q1 2026 loss narrowed year over year and topped estimates, while sales fell 5% as the Avoca divestiture and weaker end-market demand weighed on results. Is this earnings beat enough to offset the revenue pressure? Full breakdown here 👉 https://www.zacks.com/stock/news/2827565/ash-q1-earnings-beat-sales-miss-on-avoca-divestiture-weak-demand?cid=sm-stocktwits-2-2827565-teaser-31587&ADID=SYND_STOCKTWITS_TWEET_2_2827565_TEASER_31587

0 · Reply

ZacksResearch Feb. 3 at 11:06 AM

$ASH Q1: A mixed bag with a beat on earnings but a miss on sales 📉 🔹 Adjusted EPS of 26 cents topped estimates, despite a dip from last year. 🔹 Sales down 5% year over year, missing consensus due to divestitures and softer demand in key markets. 🔹 Life Sciences shines with 4% sales growth, but Personal Care and Specialty Additives lag behind. See the full breakdown of Ashland’s performance here 👉 https://www.zacks.com/stock/news/2827565/ash-q1-earnings-beat-sales-miss-on-avoca-divestiture-weak-demand?cid=sm-stocktwits-2-2827565-body-31586&ADID=SYND_STOCKTWITS_TWEET_2_2827565_BODY_31586

0 · Reply

StocktwitsEarnings Feb. 2 at 10:20 PM

$ASH Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.26 up 92.59% YoY • Reported revenue of $386M down -4.69% YoY • Ashland narrowed its full-year fiscal 2026 Adjusted EBITDA guidance to $400-$420 million, reflecting $11 million of temporary impacts. Sales are projected to be $1,835 million to $1,905 million, supported by innovation-driven product lines.

0 · Reply

Estimize Feb. 2 at 4:00 PM

$ASH reports after the close, Estimize Consensus +0.02 EPS and +0.25M Revs compared to WS http://www.estimize.com/ash/fq1-2026?utm_content=

0 · Reply

BillionerOfKing Jan. 27 at 1:10 AM

$ASH Current Stock Price: $62.47 Contracts to trade: $60 ASH Feb 20 2026 Call Entry: $3.60 Exit: $5.01 ROI: 39% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Market Cap	2.48B
Revenue (ttm)	1.82B
Net Income (ttm)	-845.00M
EPS (ttm)	N/A
PE Ratio	16.72
Forward PE	15.67
Profit Margin	-46.33%
Debt to Equity Ratio	0.74

Volume	1,846,500
Avg Vol	762,102
Day's Range	N/A - N/A
Shares Out	45.79M
Stochastic %K	90%
Beta	0.40
Analysts	Strong Sell
Price Target	$64.42